Summary The perfusion characteristics of the P22 carcinosarcoma were investigated in tissue-isolated tumour preparations in the ovarian and inguinal fat pads of BD9 rats. Tumours were perfused with a physiological buffer of known viscosity and changes in perfusion pressure were recorded at different perfusion rates in an ex vivo system. At perfusion pressures exceeding [30][31][32][33][34][35][36][37][38][39][40] The potential importance of differentially modifying tumour perfusion as a means of enhancing some forms of cancer therapy has been recently reviewed (Jirtle, 1988; Hirst & Wood, 1989; Jain, 1990) . The delivery of oxygen and other radiosensitisers is enhanced when tumour perfusion is increased, as is the delivery of chemotherapeutic agents to the tumour, whilst reducing tumour blood flow has been shown to have value in the response of tumours to hyperthermia. The identification of those factors which may be modified to produce a preferential change in tumour perfusion could have important implications for therapy.
Summary The perfusion characteristics of the P22 carcinosarcoma were investigated in tissue-isolated tumour preparations in the ovarian and inguinal fat pads of BD9 rats. Tumours were perfused with a physiological buffer of known viscosity and changes in perfusion pressure were recorded at different perfusion rates in an ex vivo system. At perfusion pressures exceeding 30-40 mmHg tumour flow rate was directly proportional to the perfusion pressure in all tumours, indicating a constant resistance to flow. An apparent positive pressure difference across the tumour vasculature of 20-30 mmHg occurred under conditions of zero flow in either site. At low perfusion pressures, the flow resistance increased sharply due to increases in the geometric resistance of the tumours. These findings are in accord with previously published data. Geometric resistance increased with tumour volume in both sites and was approximately five times greater in the inguinal tumours than it was in the ovarian tumours, on a weight to weight basis. The dependence of tumour geometric resistance on perfusion pressure differs from the situation in normal tissues and may provide a means of manipulating the tumour microcirculation to the exclusion of the systemic blood supply. The dependence of geometric resistance on tumour site may partly explain why tumours located in different sites respond differently to various forms of therapy.
The potential importance of differentially modifying tumour perfusion as a means of enhancing some forms of cancer therapy has been recently reviewed (Jirtle, 1988; Hirst & Wood, 1989; Jain, 1990) . The delivery of oxygen and other radiosensitisers is enhanced when tumour perfusion is increased, as is the delivery of chemotherapeutic agents to the tumour, whilst reducing tumour blood flow has been shown to have value in the response of tumours to hyperthermia. The identification of those factors which may be modified to produce a preferential change in tumour perfusion could have important implications for therapy.
Tumour perfusion rate, q, is dependent on the pressure gradient across the tumour vascular bed, AP, and on the resistance to flow, FR, imposed by the geometric resistance of the vasculature, z, and the viscosity of the perfusing fluid, ij:
Ex vivo perfusion of tissue-isolated tumours supplied by a single artery and drained by a single vein permits determination of both FR and z, if i is known, of a tumour over a range of perfusion pressures (Sevick & Jain, 1989a,b) . In the rat, there are two suitable sites in which tissue-isolated tumours can be grown, the ovarian and inguinal fat pads (Gullino & Grantham, 1961; Grantham et al., 1973) .
One of the many problems encountered in trying to predict the outcome of various forms of cancer therapy is the variability of the response of tumours of the same type located in different sites to physiological manipulations (Hirst et al., 1991) . Using the two isolated tumour models, the opportunity exists to characterise the physiological parameters governing perfusion in each site and this may provide an indication as to the mechanism behind the site dependency of tumour response to treatment.
Materials and methods

Animals and tumour
A transplanted rat carcinosarcoma, designated P22, was used for these experiments. This tumour arose in the treated site Immediately following surgery, the teeth and claws of all rats were clipped. This was found necessary to prevent the wound from opening and was repeated 3 days after surgery.
Subcutaneous administration of a few millilitres of dextrose/ saline solution ensured rapid rehydration of the animals postoperatively. The rats were then kept warm on a heating blanket until partial consciousness was regained. They were then caged separately and provided with soft diet for the first week after surgery.
Exteriorisation of isolated tumours for ex vivo perfusion
Perfusion experiments were carried out on tumours after a 3-4 week growth period. The rats were anaesthetised and body temperature was maintained at 37°C by a thermostatically controlled heated pad. Having checked the viability of the isolated tumours after the removal of the isolating material, the carotid artery and jugular vein were catheterised, permitting the continual monitoring of arterial blood pressure (transducer model P23XL, Spectramed) and the i.v. administration of further anaesthetic and 300 USP units heparin immediately prior to catheterising the venous side of the tumour vasculature. For tumours located in the ovarian fat pad the aorta and left renal vein were catheterised and the left kidney was excised, as described by Sevick & Jain (1989a) . For those located in the inguinal fat pad, catheters were placed in the saphenous artery and the femoral vein. Perfusion of Krebs-Henseleit (KH) buffer, pH 7.4 (Sigma Chemical Co. Ltd.), containing 5% bovine serum albumin (Sigma), 7 USP units ml-' sodium heparin (CP Pharmaceuticals Ltd.) and 1.5 mM papaverine (Sigma) was initiated immediately following the catheterisation of the arterial side of the tumour, maintaining the arterial blood pressure at normal values (t 100 ± 20 mmHg). The viscosity of the buffer was 1.0 ± 0.1 cP (Cone & Plate Viscometer, model LVDVIII, Brookfield Viscometers). The systemic supply to the tumour was then tied so that only perfusate supplied the tumour, with the venous perfusate draining to atmosphere. The animal was killed with a lethal dose of 200 mg ml-l sodium pentobarbitone (Euthatal, May & Baker Ltd.) administered via the catheter in the jugular vein. The catheterised isolated tumour was then placed in an environmentally controlled chamber, permitting experiments to be performed. Perfuslorn pressure (mmHg) initially at t 25 ml h-' for the ovarian tumours or at ; 15 ml h-' for the inguinal tumours to produce arteriovenous pressure differences of 60-80 mmHg. Flow resistance of isolated tumours
The resistance to flow at any given pressure in the two tissue-isolated tumours was calculated and plotted as a function of perfusion pressure (Figure 2 Correlation offlow rate and geometric resistance with weight The rate of perfusion required to maintain a constant perfusion pressure of 60 mmHg (q60) decreases significantly with increasing tumour size in both ovarian (r2 = 0.72) and inguinal (r2 = 0.81) sites, with the effect being more marked in the inguinal tumours (Figure 3a) . Tumour mass, w, also correlates significantly with the resistance to flow imposed by the vascular geometry of the tumours. Figure 3b shows the linear relationship between w and z0 producing the relationships:
Ovarian: z0 = (3.93 ± 0.28) x 108 w (r2 = 0.84) Inguinal: zo = (1.94 ± 0.11) x 109 w (r2 = 0.86) Thus, at any given tumour size, the 109 geometric resistance will be ; 5 times greater if the tumour is located in the inguinal fat pad, a difference of statistical significance (P< 0.001). (Whittaker & Winton, 1933; Hint, 1964; Sutera et al., 1988; Sevick & Jain, 1989a (Sevick & Jain, 1989a) . The magnitude of this value suggests that it cannot be attributed to tissue oedema alone, which is greatly reduced by the inclusion of albumin in the perfusate used in the present experiments. Consequently, the tumour vasculature must exhibit an increased resistance to flow as the perfusion pressure is reduced towards APO. This characteristic of the tumour vasculature, absent in normal tissues, theoretically provides a means of manipulating the tumour microcirculation without affecting the systemic circulation, although the hypotension that would need to be induced to initiate the increase in FR is not clinically feasible.
The increase in FR at low perfusion pressures must arise from an elevation of the geometric resistance of the tumour, since the viscosity of the KH buffer, a fluid with Newtonian properties, is constant. The magnitude of the increase in geometric resistance (Figure 2) implies that there must be some compression of the resistance vessels (z a 1/r4), possibly resulting in vascular collapse. This will occur if the pressure inside the vessels is unable to overcome the combination of extravascular pressures exerted by the fluid in the interstitium, i.e. the interstitial fluid pressure (IFP), and the pressure resulting from the proliferation of cancer cells within a confined and relatively non-compliant space (Pa). At low perfusion pressures these extravascular pressures could be greater than the intravascular pressure causing vascular collapse. A recent study using the isolated R3230AC tumour infers that the interstitial hypertension, commonly measured in experimental and human tumours (Boucher et al., 1990; Boucher et al., 1991; Roh et al., 1991; Gutmann et al., 1992) is driven by an increase in microvascular pressure arising from the high permeability of the tumour vasculature and the absence of a functional lymphatic circulation (Boucher & Jain, 1992 (Cataland et al., 1962; Vaupel, 1975; Song et al., 1980; Sevick & Jain, 1989a; Tozer et al., 1990) . Ex vivo perfusion of inguinal and ovarian isolated tumours shows that this dependence applies at physiological perfusion pressures. The increased resistance of larger tumours is probably a function of the extravascular pressures. Tumour IFP is significantly greater in the centre of the growing mass than it is at the periphery, with a marked decrease occurring at depths of <0.8-1.0 mm (Boucher et al., 1990 (Vogel, 1965) . However, the overall effect is an increase in the geometric resistance of larger tumours, since the increased resistance in the central areas of the tumour outweighs any reduced peripheral effects. This is augmented by the increased PC arising from cellular proliferation.
Whilst the behaviour of isolated tumours of the same tumour type implanted in two different sites bears a notable similarity with respect to the dependence of flow rate and flow resistance on both perfusion pressure and tumour size, tumours of equivalent weights displayed marked differences in their resistance to flow, dependent on their site of growth.
The geometric resistance of the isolated P22 carcinosarcoma was approximately five times greater in the inguinal site than in the ovarian site. This difference must be dependent on the actual tumour mass itself and not on the resistance imposed by the feeding artery. Under the conditions employed in this study, the inclusion of papaverine in the perfusate produces maximal vasodilation of the host vessels. Furthermore, the relative dimensions of the epigastric artery and the ovarian artery would tend to favour a higher resistance in the ovarian vessel. Severing the tumour from its feeding artery in either site abolishes all measurable resistance in the system, so arterial resistance must be negligible.
The possibility that the enclosing material may affect z must also be considered. The difficulties experienced when using parafilm in Information on IFP and PC in these tumours may enable a more complete picture to be drawn. If the IFP is lower in the ovarian fat pad tumour, then vascular compression and the geometric resistance will be considerably reduced. The constraints of the site of tumour growth suggest that PC could be greater in the inguinal site. Without further studies, however, this remains speculative.
The dependence of FR on tumour location may relate to the response of tumours located in different sites to various haemodynamic and vasoactive alterations. Anaemia has been shown to significantly reduce the relative perfusion of CaNT tumours implanted intradermally on the back of CBA mice whilst having little effect on the perfusion rate of tumours implanted in the abdominal fat pad (Sensky et al., 1993) . This may be due to a lower FR in the abdominal site arising from its less constrained growth site. Similarly, the vasodilators hydralazine and 5-HT, and the vasoconstrictor angiotensin II produce different effects on the perfusion of tumours which depend on their location (Hirst et al., 1991) . The use of ex vivo isolated tumours growing in two sites with different FR's enables further investigations to establish whether FR is an important determinant of response to such agents.
